{"9qXvUQMAAAAJ": [["John L Sievenpiper", 2020, "Effect of fructose and its epimers on postprandial carbohydrate metabolism: a systematic review and meta-analysis"], ["Catherine R Braunstein", 2020, "Effect of fructose and its epimers on postprandial carbohydrate metabolism: a systematic review and meta-analysis"], ["Thomas MS Wolever", 2020, "Effect of fructose and its epimers on postprandial carbohydrate metabolism: a systematic review and meta-analysis"], ["Cyril WC Kendall", 2020, "Effect of fructose and its epimers on postprandial carbohydrate metabolism: a systematic review and meta-analysis"], ["Sonia Blanco Mejia", 2020, "Effect of fructose and its epimers on postprandial carbohydrate metabolism: a systematic review and meta-analysis"], ["Jarvis C Noronha", 2020, "Effect of fructose and its epimers on postprandial carbohydrate metabolism: a systematic review and meta-analysis"], ["Tauseef A Khan", 2020, "Effect of fructose and its epimers on postprandial carbohydrate metabolism: a systematic review and meta-analysis"], ["Robert G Josse", 2020, "Effect of fructose and its epimers on postprandial carbohydrate metabolism: a systematic review and meta-analysis"], ["Robert Josse", 2020, "Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 \u2026"], ["Fei Au-Yeung", 2020, "Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 \u2026"], ["Mi-Kyung Sung", 2020, "Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 \u2026"], ["Andreea Zurbau", 2020, "Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 \u2026"], ["Allison Komishon", 2020, "Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 \u2026"], ["Vladimir Vuksan", 2020, "Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 \u2026"], ["Alexandra L Jenkins", 2020, "Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 \u2026"], ["Elena Jovanovski", 2020, "Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 \u2026"], ["Jerilynn Prior", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Mitchell AH Levine", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Jonathan D Adachi", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Guowei Li", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["David Goltzman", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Christopher S Kovacs", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Jie Zeng", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Alexandra Papaioannou", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["William D Leslie", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Canadian Multicentre Osteoporosis Study (CaMos) Research Group", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Yong Qi", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Junzhan Tian", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Tanveer Towheed", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Lehana Thabane", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["K Shawn Davison", 2020, "Combining frailty and trabecular bone score did not improve predictive accuracy in risk of major osteoporotic fractures"], ["Jerilynn C Prior", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Enisa Shevroja", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Stephanie M Kaiser", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Andr\u00e9 G Uitterlinden", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Didier Hans", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Josje Schoufour", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Fjorda Koromani", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["M Carola Zillikens", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Olivier Lamy", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Fernando Rivadeneira", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Eugene McCloskey", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Edwin H Oei", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Ling Oei", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Tassos Anastassiades", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Gabriel P Krestin", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Oscar H Franco", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Katerina Trajanoska", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Brian C Lentle", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["M Arfan Ikram", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["Taulant Muka", 2020, "Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone"], ["William Leslie", 2019, "Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals"], ["Brian Lentle", 2019, "Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals"], ["Andre Uitterlinden", 2019, "Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals"], ["Oscar Franco", 2019, "Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals"], ["Gabriel Krestin", 2019, "Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals"], ["Carola Zillikens", 2019, "Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals"], ["Arfan Ikram", 2019, "Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals"], ["Stephanie Kaiser", 2019, "Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals"], ["Edwin Oei", 2019, "Type 2 Diabetes Mellitus and the risk of osteoporotic vertebral fractures: a meta-analysis of summary and individual participant data from 852,705 individuals"], ["Lindsie Blencowe", 2019, "Serum Pentosidine in Women in the Canadian Multicentre Osteoporosis Study"], ["Andrea Bozovic", 2019, "Serum Pentosidine in Women in the Canadian Multicentre Osteoporosis Study"], ["Claudie Berger", 2019, "Serum Pentosidine in Women in the Canadian Multicentre Osteoporosis Study"], ["Angela Cheung", 2019, "Serum Pentosidine in Women in the Canadian Multicentre Osteoporosis Study"], ["Evelyn Wong", 2019, "Serum Pentosidine in Women in the Canadian Multicentre Osteoporosis Study"], ["Vathany Kulasingam", 2019, "Serum Pentosidine in Women in the Canadian Multicentre Osteoporosis Study"], ["Suzanne Morin", 2019, "Serum Pentosidine in Women in the Canadian Multicentre Osteoporosis Study"], ["George Tomlinson", 2019, "Serum Pentosidine in Women in the Canadian Multicentre Osteoporosis Study"], ["Christopher Kovacs", 2019, "Serum Pentosidine in Women in the Canadian Multicentre Osteoporosis Study"], ["Phillip Gregoire", 2019, "The Case| Severe symptomatic hypocalcemia in a patient with sickle cell disease"], ["Heather N Reich", 2019, "The Case| Severe symptomatic hypocalcemia in a patient with sickle cell disease"], ["Vikas Srinivasan Sridhar", 2019, "The Case| Severe symptomatic hypocalcemia in a patient with sickle cell disease"], ["Stuart A Jackson", 2019, "Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian \u2026"], ["Amanda Silvia", 2019, "Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian \u2026"], ["Suzanne N Morin", 2019, "Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian \u2026"], ["Tassos P Anastassiades", 2019, "Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian \u2026"], ["George Ioannidis", 2019, "Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian \u2026"], ["Rich Barron", 2019, "Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian \u2026"], ["Erinda Shyta", 2019, "Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian \u2026"], ["David A Hanley", 2019, "Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian \u2026"], ["Derek Weycker", 2019, "Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian \u2026"], ["Lea Smircic-Duvnjak", 2019, "Effect of coadministration of enriched Korean red ginseng (Panax ginseng) and American ginseng (Panax quinquefolius L) on cardiometabolic outcomes in type-2 diabetes: A \u2026"], ["Dandan Li", 2019, "Effect of coadministration of enriched Korean red ginseng (Panax ginseng) and American ginseng (Panax quinquefolius L) on cardiometabolic outcomes in type-2 diabetes: A \u2026"], ["Fei Rodney Au-Yeung", 2019, "Effect of coadministration of enriched Korean red ginseng (Panax ginseng) and American ginseng (Panax quinquefolius L) on cardiometabolic outcomes in type-2 diabetes: A \u2026"], ["Lisa Langsetmo", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["Piet Geusens", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["CaMOS Research Group", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["Jacqueline R Center", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["Joop van den Bergh", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["John A Eisman", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["Dana Bliuc", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["Tuan V Nguyen", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["Tineke van Geel", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["Thach Tran", 2019, "Reduced bone loss is associated with reduced mortality risk in subjects exposed to nitrogen bisphosphonates: A mediation analysis"], ["R Josse", 2019, "Hypophosphatasia: Canadian update on diagnosis and management"], ["S Van Uum", 2019, "Hypophosphatasia: Canadian update on diagnosis and management"], ["J Villeneuve", 2019, "Hypophosphatasia: Canadian update on diagnosis and management"], ["CR Greenberg", 2019, "Hypophosphatasia: Canadian update on diagnosis and management"], ["AA Khan", 2019, "Hypophosphatasia: Canadian update on diagnosis and management"], ["P Kannu", 2019, "Hypophosphatasia: Canadian update on diagnosis and management"], ["T Paul", 2019, "Hypophosphatasia: Canadian update on diagnosis and management"], ["Jonathan Adachi", 2019, "Incident Fragility Fractures Have a Long\u2010Term Negative Impact on Health\u2010Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study"], ["Angela M Cheung", 2019, "Incident Fragility Fractures Have a Long\u2010Term Negative Impact on Health\u2010Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study"], ["Courtney Kennedy", 2019, "Incident Fragility Fractures Have a Long\u2010Term Negative Impact on Health\u2010Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study"], ["CaMos Research Group", 2019, "Incident Fragility Fractures Have a Long\u2010Term Negative Impact on Health\u2010Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study"], ["Sayem Borhan", 2019, "Incident Fragility Fractures Have a Long\u2010Term Negative Impact on Health\u2010Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study"], ["Olga Gajic\u2010Veljanoski", 2019, "Incident Fragility Fractures Have a Long\u2010Term Negative Impact on Health\u2010Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study"], ["Mitchell Levine", 2019, "Frailty and risk of fractures in patients with type 2 diabetes"], ["CS Kovacs", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["JR Center", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["DA Hanley", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["L Langsetmo", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["TV Nguyen", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["Jan Van den Bergh", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["JD Adachi", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["S Kaiser", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["T van Geel", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["RG Josse", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["D Bliuc", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["C Berger", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["D Goltzman", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["T Tran", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["JC Prior", 2019, "Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study"], ["Russell J de Souza", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Sandy Mitchell", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Edward Vidgen", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Beno\u00eet Lamarche", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Balachandran Bashyam", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Monica S Banach", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Sathish C Pichika", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Christopher Ireland", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Stephanie Nishi", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Korbua Srichaikul", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["David JA Jenkins", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Tina Parker", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Joseph Beyene", 2019, "Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial"], ["Sanaz Kamalinia", 2019, "Risk of Any Hypoglycemia with New Antihyperglycemic Agents in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis"], ["Jennifer B Green", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["M Angelyn Bethel", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["TECOS Study Group", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["Jie Ding", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["Eric D Peterson", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["Irene Hramiak", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["Susanna R Stevens", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["Michael Alvarsson", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["Rury R Holman", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["Yuliya Lokhnygina", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["Samuel S Engel", 2019, "Progression of glucose\u2010lowering diabetes therapy in TECOS"], ["B Abrahamsen", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["M Chandran", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["WD Leslie", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["K Akesson", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["DL Kendler", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["AV Schwartz", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["Serge Livio Ferrari", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["R Eastell", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["DD Pierroz", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["N Napoli", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["A Suzuki", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["M Kraenzlin", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["G El-Hajj Fuleihan", 2018, "Diagnosis and management of bone fragility in diabetes: an emerging challenge"], ["Olga Gajic-Veljanoski", 2018, "The Long-term Impact of Incident Low-trauma Fractures on Health-related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study"], ["Wilma Hopman", 2018, "The Long-term Impact of Incident Low-trauma Fractures on Health-related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study"], ["Asm Borhan", 2018, "The Long-term Impact of Incident Low-trauma Fractures on Health-related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study"]]}